Neeraj Agarwal shared on X:
“Emerging treatment options in adjuvant RCC kidney cancer setting, comprehensive talk by Bradley McGregor. Principles of adjuvant therapy Kim-1 may allow patient selection and novel ongoing trials.”
Source: Neeraj Agarwal/X
Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.
